JA

Profile

Research

Social

Other

Fujita Jirou

藤田 二郎

Graduate School of Medicine Division of Medicine, Associate Professor (Lecturer)

Research Areas

  • Life sciences, Hematology and oncology

Papers

  • Successful Bridging to Allogeneic Hematopoietic Stem Cell Transplantation by Azacitidine and Venetoclax in a Case of Acute Myeloid Leukemia With t(3;3)(q21.3;q26.2) Developed Early After Orthotopic Heart Transplantation, Tomoaki Ueda,Jiro Fujita,Yasuhiro Akazawa,Ai Kawamura,Takahiro Matsui,Akihisa Hino,Shinsuke Kusakabe,Takao Sudo,Kentaro Fukushima,Takafumi Yokota,Shigeru Miyagawa,Yasushi Sakata,Naoki Hosen, Transplantation Proceedings, Elsevier BV, 2023/04
  • [Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination]., Ayami Senda,Hideaki Saito,Shinsuke Kusakabe,Koki Yoshida,Kumi Shibata,Shuhei Kida,Jun Toda,Akihisa Hino,Tomoaki Ueda,Jiro Fujita,Kentaro Fukushima,Takafumi Yokota,Hirokazu Kashiwagi,Naoki Hosen, [Rinsho ketsueki] The Japanese journal of clinical hematology, Vol. 64, No. 1, p. 35-41, 2023
  • Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation., Akihisa Hino,Kentaro Fukushima,Shinsuke Kusakabe,Tomoaki Ueda,Takao Sudo,Jiro Fujita,Daisuke Motooka,Aya K Takeda,Natsuko O Shinozaki,Satoshi Watanabe,Takafumi Yokota,Hirohiko Shibayama,Shota Nakamura,Naoki Hosen, British journal of haematology, Vol. 201, No. 4, p. 725-737, 2022/12/05
  • 同種造血幹細胞移植後ITPの診断における網状血小板比率、抗血小板自己抗体測定の意義, 芥田 敬吾,福島 健太郎,中田 継一,林 悟,堤 一仁,日野 彬央,戸田 淳,草壁 信輔,上田 智朗,藤田 二郎,加藤 恒,横田 貴史,冨山 佳昭,保仙 直毅,柏木 浩和, 日本血栓止血学会誌, (一社)日本血栓止血学会, Vol. 33, No. 2, p. 288-288, 2022/05
  • Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes., Yasunori Ueda,Kensuke Usuki,Jiro Fujita,Itaru Matsumura,Nobuyuki Aotsuka,Naohiro Sekiguchi,Tomonori Nakazato,Hiromi Iwasaki,Mariko Takahara-Matsubara,Saori Sugimoto,Masashi Goto,Tomoki Naoe,Masahiro Kizaki,Yasushi Miyazaki,Koichi Aakashi, Cancer science, Vol. 113, No. 4, p. 1377-1392, 2022/04
  • A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement., Yukiko Doi,Takafumi Yokota,Hirohiko Shibayama,Kana Matsumoto,Masako Kurashige,Kenji Nozaki,Jiro Fujita,Kentaro Fukushima,Naoki Hosen, Leukemia & lymphoma, Vol. 63, No. 4, p. 1013-1015, 2022/04
  • Autoimmune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation: significance of detecting reticulated platelets and glycoprotein-specific platelet autoantibodies., Keigo Akuta,Kentaro Fukushima,Keiichi Nakata,Satoru Hayashi,Jun Toda,Yasuhiro Shingai,Kazuhito Tsutsumi,Tomohisa Machida,Akihisa Hino,Shinsuke Kusakabe,Yukiko Doi,Jiro Fujita,Hisashi Kato,Tetsuo Maeda,Takafumi Yokota,Yoshiaki Tomiyama,Naoki Hosen,Hirokazu Kashiwagi, International journal of hematology, Vol. 115, No. 3, p. 322-328, 2022/03
  • Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report., Tomoyo Kubo,Akihisa Hino,Kentaro Fukushima,Yoshimitsu Shimomura,Masako Kurashige,Shinsuke Kusakabe,Yasuhiro Nagate,Jiro Fujita,Takafumi Yokota,Hisashi Kato,Hirohiko Shibayama,Atsushi Tanemura,Naoki Hosen, International journal of hematology, Vol. 116, No. 2, p. 302-306, 2022/02/24
  • Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS-like tyrosine kinase 3-internal tandem duplication with central nervous system involvement., Makiko Suga,Kentaro Fukushima,Tomoaki Ueda,Yasuyuki Arai,Shunsaku Nakagawa,Yosuke Minami,Jun Toda,Akihisa Hino,Jiro Fujita,Takafumi Yokota,Naoki Hosen, Clinical case reports, Vol. 10, No. 2, 2022/02
  • Inotuzumab ozogamicin and blinatumomab sequential therapy for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia., Tomoaki Ueda,Kentaro Fukushima,Shinsuke Kusakabe,Koki Yoshida,Makiko Suga,Ritsuko Nakai,Midori Koike,Akihisa Hino,Keigo Akuta,Jun Toda,Yasuhiro Nagate,Yukiko Doi,Jiro Fujita,Takafumi Yokota,Naoki Hosen, Leukemia research reports, Vol. 17, p. 100294-100294, 2022
  • Whole-exome sequencing identified mutational profile of a case with T-cell chronic lymphocytic leukemia., Kenji Nozaki,Takafumi Yokota,Eri Itotagawa,Kazuhito Tsutsumi,Shinsuke Kusakabe,Yoichiro Morikawa,Jiro Fujita,Kentaro Fukushima,Tetsuo Maeda,Hirohiko Shibayama,Naoki Hosen,Atsushi Kumanogo,Yuzuru Kanakura, Clinical case reports, Vol. 8, No. 11, p. 2251-2254, 2020/11
  • Primary central nervous system lymphoma of the bilateral Bochdalek's flower baskets: A case report, Tomoyoshi Nakagawa,Hideyuki Arita,Noriyuki Kijima,Jiro Fujita,Yasuhiro Nagate,Ryuichi Hirayama,Manabu Kinoshita,Naoki Kagawa,Haruhiko Kishima, Interdisciplinary Neurosurgery: Advanced Techniques and Case Management, Vol. 21, 2020/09
  • Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation., Jun Toda,Tetsuo Maeda,Keigo Akuta,Shinsuke Kusakabe,Tomoaki Ueda,Jiro Fujita,Hirohiko Shibayama,Kenji Oritani,Yukitoshi Takahashi,Yuzuru Kanakura, International journal of hematology, Vol. 112, No. 2, p. 254-257, 2020/08
  • Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function, Yasuhiro Nagate,Sachiko Ezoe,Jiro Fujita,Daisuke Okuzakis,Daisuke Motooka,Tomohiko Ishibashi,Michiko Ichii,Akira Tanimura,Masako Kurashige,Eiichi Morii,Takuya Fukushima,Youko Suehiro,Takafumi Yokota,Hirohiko Shibayama,Kenji Oritani,Yuzuru Kanakura, Leukemia, 2020/03/20
  • 悪性黒色腫に対するニボルマブ治療後に溶血性貧血を伴う多発リンパ節腫大を認めた1例, 久保 茂世,日野 彬央,藤田 二郎,福島 健太郎,加藤 恒,横田 貴史,柴山 浩彦, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 61, No. 2, p. 197-198, 2020/02
  • Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation., Shinsuke Kusakabe,Kentaro Fukushima,Takafumi Yokota,Akihisa Hino,Jiro Fujita,Daisuke Motooka,Shota Nakamura,Hirohiko Shibayama,Yuzuru Kanakura, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020/02/01
  • Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation., Shinsuke Kusakabe,Kentaro Fukushima,Tetsuo Maeda,Daisuke Motooka,Shota Nakamura,Jiro Fujita,Takafumi Yokota,Hirohiko Shibayama,Kenji Oritani,Yuzuru Kanakura, British journal of haematology, Vol. 188, No. 3, p. 438-449, 2020/02
  • 大細胞転化を伴うmycosis fungoidesの治療経過中、まれな膵転移による膵炎により治療が難渋した1例, 爲政 萌子,前川 亜耶,清原 英司,横井 一範,藤本 学,長手 泰宏,藤田 二郎, 日本皮膚科学会雑誌, (公社)日本皮膚科学会, Vol. 130, No. 1, p. 92-92, 2020/01
  • 原発性骨髄線維症に対する非血縁者間骨髄移植後造血が遷延したが、病理組織学的に線維化および骨硬化の改善が確認された1例, 矢島 綾子,草壁 信輔,福島 健太郎,藤田 二郎,横田 貴史,柴山 浩彦,金倉 譲,倉重 真沙子,森井 英一, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 60, No. 10, p. 1487-1487, 2019/10
  • 免疫不全の要素を有さない若年男性に生じた、形質芽球様の組織像を呈するCD56陰性EBER1陰性atypical extraosseous plasmacytomaの一例, 中井 りつこ,植田 康敬,和田 直樹,日野 彬央,草壁 信輔,土居 由貴子,長手 泰宏,藤田 二郎,福島 健太郎,横田 貴史,柴山 浩彦,森井 英一,金倉 譲, 日本リンパ網内系学会会誌, (一社)日本リンパ網内系学会, Vol. 59, p. 138-138, 2019/05
  • Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation., Tomoaki Ueda,Tetsuo Maeda,Shinsuke Kusakabe,Jiro Fujita,Kentaro Fukushima,Takafumi Yokota,Hirohiko Shibayama,Yoshiaki Tomiyama,Yuzuru Kanakura, International journal of hematology, Vol. 109, No. 2, p. 197-205, 2019/02
  • Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome., Kenji Nozaki,Sachiko Ezoe,Masanari Hamaguchi,Kazuhito Tsutsumi,Shinsuke Kusakabe,Yoichiro Morikawa,Jiro Fujita,Kentaro Fukushima,Tetsuo Maeda,Hirohiko Shibayama,Atsushi Kumanogo,Yuzuru Kanakura, European journal of case reports in internal medicine, Vol. 6, No. 11, p. 001266-001266, 2019
  • A Novel Unifrac-Based Analytical Method for Determining Sequential Changes in Gut Microbiota after Hematopoietic Stem Cell Transplantation, Kusakabe Shinsuke,Fukushima Kentaro,Maeda Tetsuo,Yokota Takafumi,Nakai Ritsuko,Hino Akihisa,Nagate Yasuhiro,Fujita Jiro,Daisuke Motooka,Nakamura Shota,Shibayama Hirohiko,Kanakura Yuzuru, The American Society of Hematology 60th Annual Meeting, Vol. 132, 2018/11
  • 造血幹細胞移植後腸内細菌叢のUniFrac解析をもとにした検討(UniFrac analysis of gut microbiota following hematopoietic stem cell transplantation), 草壁 信輔,前田 哲生,中井 りつこ,日野 彬央,長手 泰宏,福島 健太郎,藤田 二郎,元岡 大佑,中村 昇太,柴山 浩彦,織谷 健司,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 59, No. 9, p. 1811-1811, 2018/09
  • Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation, Mikiko Sakuragi,Satoru Hayashi,Miho Maruyama,Tomoko Kiyokawa,Keisuke Nagamine,Jiro Fujita,Tetsuo Maeda,Hisashi Kato,Hirokazu Kashiwagi,Yuzuru Kanakura,Yoshiaki Tomiyama, International Journal of Hematology, Springer Tokyo, Vol. 107, No. 3, p. 320-326, 2018/03/01
  • 第1寛解期にhematogonesを認め、再発との鑑別に苦慮した急性リンパ性白血病の1例, 清水 成,堤 一仁,野崎 健司,草壁 信輔,森川 陽一郎,藤田 二郎,前田 哲生,柴山 浩彦,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 59, No. 2, p. 232-232, 2018/02
  • Autoimmune bullous disease and Hashimoto's disease complicated by acquired hemophilia A., Nishiura N,Ujimoto D,Fujita J,Maeda T,Nakagawa Y,Kashiwagi H,Oritani K,Tomiyama Y,Kanakura Y, [Rinsho ketsueki] The Japanese journal of clinical hematology, The Japanese Society of Hematology, Vol. 58, No. 3, p. 233-238, 2017
  • Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88L265P mutation., Toru Kida,Akira Tanimura,Akihiro Ono,Takahiro Matsui,Keiichiro Honma,Jiro Fujita,Tetsuo Maeda,Hirohiko Shibayama,Kenji Oritani,Eiichi Morii,Yuzuru Kanakura, [Rinsho ketsueki] The Japanese journal of clinical hematology, Vol. 58, No. 2, p. 155-160, 2017
  • Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax, Takahiro Matsui,Tetsuo Maeda,Toru Kida,Jiro Fujita,Hiromi Tsuji,Eiichi Morii,Yuzuru Kanakura, INTERNATIONAL JOURNAL OF HEMATOLOGY, SPRINGER JAPAN KK, Vol. 104, No. 4, p. 525-530, 2016/10
  • Large cell transformationに伴いMYD88遺伝子変異が出現したLPLの1例, 小野 晃裕,木田 亨,谷村 朗,藤田 二郎,前田 哲生,柴山 浩彦,織谷 健司,金倉 譲,松井 崇浩,本間 圭一郎,森井 英一, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 57, No. 2, p. 188-188, 2016/02
  • 多彩な神経症状を呈した濾胞性リンパ腫の1例, 内田 紘史,芥田 敬吾,水木 満佐央,前田 哲生,藤田 二郎,田所 誠司,織谷 健司,金倉 譲,薮本 大紀,高橋 正紀, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 56, No. 11, p. 2382-2382, 2015/11
  • Diffuse large B-cell lymphoma occurring in a Waldenström macroglobulinemia patient with central nervous system infiltration., Hayashi Y,Sata H,Akuta K,Toda J,Kusakabe S,Ueda T,Ueda Y,Fujita J,Tadokoro S,Maeda T,Nishimura J,Shibayama H,Oritani K,Kanakura Y, Rinsho Ketsueki, Vol. 56, No. 11, p. 2351-2356, 2015/11
  • Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients, Hiroshi Sata,Hirohiko Shibayama,Ikuhiro Maeda,Yoko Habuchi,Eiji Nakatani,Kentaro Fukushima,Jiro Fujita,Sachiko Ezoe,Seiji Tadokoro,Tetsuo Maeda,Masao Mizuki,Satoru Kosugi,Masashi Nakagawa,Shuji Ueda,Masato Iida,Yukihiro Tokumine,Yasuhiko Azenishi,Hideki Mitsui,Kenji Oritani,Yuzuru Kanakura, EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, Vol. 43, No. 5, p. 374-381, 2015/05
  • 自己免疫性好中球減少症に合併した自己免疫性溶血性貧血に対して、部分的脾動脈塞栓術を施行した1例, 堤 一仁,戸田 淳,前田 哲生,藤田 二郎,田所 誠司,織谷 健司,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 56, No. 1, p. 72-72, 2015/01
  • Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine, Maeda T,Hosen N,Fukushima K,Tsuboi A,Morimoto S,Matsui T,Sata H,Fujita J,Hasegawa K,Nishida S,Nakata J,Nakae Y,Takashima S,Nakajima H,Fujiki F,Tatsumi N,Kondo T,Hino M,Oji Y,Oka Y,Kanakura Y,Kumanogoh A,Sugiyama H, BLOOD CANCER JOURNAL, Vol. 3, No. 8, 2013/08
  • Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells, Jiro Fujita,Masao Mizuki,Masayasu Otsuka,Sachiko Ezoe,Hirokazu Tanaka,Yusuke Satoh,Kentaro Fukushima,Masahiro Tokunaga,Itaru Matsumura,Yuzuru Kanakura, IMMUNOLOGY LETTERS, ELSEVIER SCIENCE BV, Vol. 136, No. 1, p. 61-73, 2011/04
  • Constitutively Active FGFR3 with Lys650Glu Mutation Enhances Bortezomib Sensitivity in Plasma Cell Malignancy, Masayasu Otsuka,Masao Mizuki,Jiro Fujita,Sumin Kang,Yuzuru Kanakura, ANTICANCER RESEARCH, INT INST ANTICANCER RESEARCH, Vol. 31, No. 1, p. 113-122, 2011/01
  • Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma., Hidetsugu Kawai,Kiyoshi Ando,Dai Maruyama,Kazuhito Yamamoto,Eiji Kiyohara,Yasuhito Terui,Noriko Fukuhara,Tomomitsu Miyagaki,Yoshiki Tokura,Mamiko Sakata-Yanagimoto,Tadahiko Igarashi,Junya Kuroda,Jiro Fujita,Toshiki Uchida,Takayuki Ishikawa,Kentaro Yonekura,Koji Kato,Tadashi Nakanishi,Kenya Nakai,Risa Matsunaga,Kensei Tobinai, Cancer science, Vol. 112, No. 6, p. 2426-2435, 2021/06
  • High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder, Hideaki Saito,Hiroaki Miyoshi,Hirohiko Shibayama,Jun Toda,Shinsuke Kusakabe,Michiko Ichii,Jiro Fujita,Kentaro Fukushima,Tetsuo Maeda,Masao Mizuki,Kenji Oritani,Masao Seto,Takafumi Yokota,Yuzuru Kanakura,Naoki Hosen,Koichi Ohshima, International Journal of Hematology, Springer Science and Business Media LLC, 2021/03/25
  • 卵巣がんに合併したホジキンリンパ腫の1例, 竹内 甲,上田 智朗,藤田 二郎,福島 健太郎,西村 純一,保仙 直毅,倉重 真沙子,森井 英一, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 62, No. 3, p. 208-208, 2021/03
  • 造血幹細胞移植後の血小板減少におけるRP%、TPO濃度、抗GPIIb/IIIa抗体測定の意義, 福島 健太郎,芥田 敬吾,加藤 恒,柏木 浩和,林 悟,日野 彬央,新開 泰宏,藤田 二郎,横田 貴史,保仙 直毅,冨山 佳昭, 日本血栓止血学会誌, (一社)日本血栓止血学会, Vol. 31, No. 2, p. 241-241, 2020/05
  • Addition of Melphalan to Fludarabine/Busulfan (FLU/BU4/MEL) Provides Survival Benefit for Patients with Myeloid Malignancy Following Allogeneic Bone Marrow Transplantation/Peripheral Blood Stem Cell Transplantation, Ueda Tomoaki,Maeda Tetsuo,Fukushima Kentaro,Fujita Jiro,Kusakabe Shinsuke,Yokota Takafumi,Shibayama Hirohiko,Tomiyama Yoshiaki,Kanakura Yuzuru, The American Society of Hematology 60th Annual Meeting, Vol. 132, 2018/11

Misc.

  • COVID-19ワクチン接種後発症した後天性血友病A, 千田郁実,西東秀晃,草壁信輔,吉田好機,柴田久美,紀田修平,戸田淳,日野彬央,上田智朗,藤田二郎,福島健太郎,横田貴史,保仙直毅, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 63, No. 2, p. 144-144, 2022
  • Successful treatment of refractory FLT3-ITD acute myeloid leukemia with Quizartinib prior to CBT, 菅真紀子,福島健太郎,上田智朗,吉田好機,小池翠,戸田淳,芥田敬吾,日野彬央,土居由貴子,長手泰宏,藤田二郎,横田貴史,保仙直毅, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 43rd, 2021
  • Bridging therapy to allogeneic stem cell transplantation with Inotuzumab/Blinatumomab for R/R Ph1ALL, 吉田好機,福島健太郎,菅真紀子,芥田敬吾,上田智朗,日野彬央,土居由貴子,長手泰宏,藤田二郎,横田貴史,保仙直毅, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 43rd, 2021
  • The impact of Gemtuzumab Ozogamicin for Busulfan-Cyclophosphamide conditioning resistant AML blasts, 草壁信輔,福島健太郎,吉田好機,中田継一,小池翠,日野彬央,土居由貴子,長手泰宏,高橋雅文,藤田二郎,横田貴史,柴山浩彦,金倉譲,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 42nd, 2020
  • A case of disseminated varicella-zoster virus infection with MRI findings characteristic of PRES after allo-SCT, 中井りつこ,福島健太郎,吉田好機,中田潤一,小池翠,日野彬央,草壁信輔,長手泰宏,土居由貴子,藤田二郎,横田貴史,柴山浩彦,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 42nd, 2020
  • Exophiala属による真菌血症をきたし致死的な経過を辿った同種造血幹細胞移植後の2例, 中井りつこ,福島健太郎,日野彬央,草壁信輔,長手泰宏,藤田二郎,横田貴史,柴山浩彦,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 41st, 2019
  • Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through the Adenosine Pathway, Yasuhiro Nagate,Sachiko Ezoe,Jiro Fujita,Takafumi Yokota,Michiko Ichii,Akira Tanimura,Yukiko Doi,Tomoaki Ueda,Jun Toda,Hirohiko Shibayama,Kenji Oritani,Yuzuru Kanakura, BLOOD, AMER SOC HEMATOLOGY, Vol. 132, 2018/11
  • R-CHOP療法中に閉塞性細気管支炎(BO)を発症した濾胞性リンパ腫の1例, 野崎 健司,江副 幸子,堤 一仁,草壁 信輔,森川 陽一郎,藤田 二郎,福島 健太郎,前田 哲生,柴山 浩彦,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 59, No. 11, p. 2486-2486, 2018/11
  • ATLL細胞はCD39を高発現し、Adenosine経路を介して免疫応答を抑制する(CD39 is highly expressed on ATLL cells and suppresses immune response through the adenosine pathway), 長手 泰宏,江副 幸子,藤田 二郎,横田 貴史,一井 倫子,谷村 朗,濱中 有理,土居 由貴子,上田 智朗,戸田 淳,柴山 浩彦,織谷 健司,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 59, No. 9, p. 1495-1495, 2018/09
  • 寛解導入中にMRSA胎盤膿瘍をきたしたAPLの1例, 吉田 好機,草壁 信輔,堤 一仁,野崎 健司,森川 陽一郎,福島 健太郎,藤田 二郎,前田 哲生,柴山 浩彦,金倉 譲,祝 小百合,香林 正樹,瀧内 剛, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 59, No. 2, p. 232-232, 2018/02
  • 造血幹細胞移植後腸内細菌叢のUniFrac解析をもとにした検討, 草壁信輔,前田哲生,中井りつこ,日野彬央,長手泰宏,福島健太郎,藤田二郎,元岡大佑,中村昇太,柴山浩彦,織谷健司,金倉譲, 臨床血液, Vol. 59, No. 9, 2018
  • ECTONUCLEOTIDASES CD39/CD73 ARE HIGHLY EXPRESSED ON ATLL CELLS AND RESPONSIBLE FOR GENERATING AMP/ADENOSINE, Y. Nagate,S. Ezoe,J. Fujita,M. Ichii,J. Toda,K. Oritani,Y. Kanakura, HAEMATOLOGICA, FERRATA STORTI FOUNDATION, Vol. 102, p. 563-563, 2017/06
  • 造血幹細胞移植後に発症したNMDA型GluR抗体陽性脳炎の1例, 戸田淳,前田哲生,芥田敬吾,草壁信輔,上田智朗,藤田二郎,織谷健司,高橋幸利,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 39th, 2017
  • 同種造血幹細胞移植における腸内細菌叢の経時的な解析, 草壁信輔,前田哲生,堤一仁,野崎健司,森川陽一郎,藤田二郎,元岡大祐,中村昇太,柴山浩彦,織谷健司,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 40th, 2017
  • Endothelial Cell-Selective Adhesion Molecule (ESAM) Is Required for the Ontogeny of Definitive Hematopoietic System in Mice, Tomoaki Ueda,Takafumi Yokota,Yasuhiro Shingai,Yukiko Doi,Tomohiko Ishibashi,Takao Sudo,Yasuhiro Nagate,Akira Tanimura,Masahiro Tokunaga,Jiro Fujita,Michiko Ichii,Sachiko Ezoe,Hirohiko Shibayama,Kenji Oritani,Yuzuru Kanakura, BLOOD, AMER SOC HEMATOLOGY, Vol. 128, No. 22, 2016/12
  • 同種造血幹細胞移植後HHV6脳炎11例における髄液と血液におけるHHV6 DNA量の検討, 草壁信輔,前田哲生,西浦伸子,倉重隆明,西東秀晃,新開泰宏,高森弘之,木田亨,藤田二郎,横田貴史,織谷健司,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 38th, 2016
  • FLU/BU/MELを前処置とした骨髄系腫瘍に対する同種造血幹細胞移植の成績, 上田智朗,前田哲生,倉重隆明,西東秀晃,新開泰宏,西浦伸子,高森弘之,木田亨,草壁信輔,藤田二郎,横田貴史,織谷健司,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 38th, 2016
  • 移植後重症腸炎の発症に発疹を伴わずに再活性化したHHV-6が関与した一例, 島本晃一,佐多弘,芥田敬吾,戸田淳,草壁信輔,上田智朗,植田康敬,藤田二郎,田所誠司,横田貴史,前田哲生,織谷健司,金倉譲, 日本造血細胞移植学会総会プログラム・抄録集, Vol. 37th, 2015
  • 発作性夜間ヘモグロビン尿症合併大腸癌患者のエクリズマブ投与による周術期管理, 栗原 智樹,数藤 孝雄,福島 健太郎,西村 純一,江副 幸子,藤田 二郎,前田 哲生,田所 誠司,柴山 浩彦,織谷 健司,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 55, No. 2, p. 270-270, 2014/02
  • FDG‐PETで坐骨神経に沿って異常集積を呈した1例, 今泉昌男,巽光朗,柴田大,藤田二郎,金井泰和,仲定宏,加藤弘樹,渡部直史,礒橋佳也子,渡辺晋一郎,花本敦,花岡宏平,渡部浩司,下瀬川恵久,金倉譲,畑澤順, 核医学症例検討会症例集, Vol. 33, No. 1, p. 1-2, 2012/08
  • 坐骨神経痛にて発症したNeurolymphomatosisと思われるDLBCLの1例, 柴田 大,藤田 二郎,福島 健太郎,江副 幸子,前田 哲生,田所 誠司,水木 満佐央,織谷 健司,金倉 譲, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 53, No. 8, p. 790-790, 2012/08
  • 造血器腫瘍関連遺伝子異常が樹状細胞分化に及ぼす影響の解析, 藤田 二郎,水木 満佐央,大塚 正恭,江副 幸子,佐藤 友亮,福島 健太郎,徳永 正浩,田中 宏和,松村 到,金倉 譲, Cytometry Research, (一社)日本サイトメトリー学会, Vol. 22, No. Suppl., p. 65-65, 2012/06
  • 非炎症状態の樹状細胞分化における白血病関連遺伝子異常の役割(Leukemia-related gene abnormalities affect steady-state dendritic cell differentiation), 藤田 二郎,水木 満佐央,江副 幸子,田中 宏和,佐藤 友亮,福島 健太郎,徳永 正浩,松村 到,金倉 譲, 日本癌学会総会記事, 日本癌学会, Vol. 69回, p. 161-161, 2010/08
  • Study of Lymphocyte Extraction and Treatment Outcomes in Kymriah for Relapsed/Refractory DLBCL, 村上拓,水谷陽,杉本彩乃,遠藤誉也,吉田好機,町田朋久,倉重隆明,笠原秀範,日野彬央,草壁信輔,上田智朗,数藤孝雄,藤田二郎,福島健太郎,加藤恒,保仙直毅, 日本造血・免疫細胞療法学会総会プログラム・抄録集, Vol. 45th, 2022
  • Optimal treatment with Ibrutinib as a second-line treatment for steroid dependent/refractory cGVHD, 水谷陽,上田智朗,福島健太郎,杉本彩乃,遠藤誉也,村上拓,吉田好機,菅真紀子,柴田久美,中田継一,中井りつこ,堤一仁,紀田修平,町田朋久,小池翠,倉重隆明,日野彬央,笠原秀範,草壁信輔,数藤孝雄,植田康敬,一井倫子,柏木浩和,水木満佐央,藤田二郎,加藤恒,保仙直毅, 日本造血・免疫細胞療法学会総会プログラム・抄録集, Vol. 45th, 2022